Annovis Bio Inc. (NYSE: ANVS) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 60+ brands within the Dynamic Brand Portfolio @ IBN ( InvestorBrandNetwork), a ...

The Longeveron investor presentation to be used at the conference is available at the “ Events & Presentations ” section of the Company’s website. About Longeveron Inc.

Earlier in September, Femasys announced its strategic distribution partnerships for FemaSeed and FemVue in Spain. Comercial Medico Quirurigca, SA (CMQ) will distribute the products in northern Spain ...

IntelGenx Technologies Corp. (the “Company” or “IntelGenx”), a leading drug delivery company focused on the development and manufacturing of pharmaceutical films, announces that the Company and its ...

3rd Annual ROTH Healthcare Opportunities Conference Format: Panel discussion ( Opportunities and Challenges When Small Names Go After Blockbuster Indications) and one-on-one investor meetings Date: ...

EnnoDC* (or “the Company”), a clinical-stage biotech company pioneering the development of first-in-class dendritic cell-targeting immunotherapies, today notes the publication of positive results from ...

As October marks World Menopause Awareness Month, ARC Fertility (ARC), a highly experienced national provider of innovative fertility, family-forming and women’s and men’s health benefits for ...

Climb Bio will begin trading on Nasdaq under the trading symbol "CLYM" effective October 3rd ...

NXC-201 is the only CAR-T therapy currently in development in AL Amyloidosis, mentioned in a review article entitled “Systemic Light Chain Amyloidosis” published in June, 2024 New England Journal of ...

NADP Marks Successes as Recognized Representative and Resource of Dental Benefits Industry ...

Today, DepYmed announces co-founder and research advisor Nicholas Tonks, Ph.D. will present data at the 9 th World Rett Syndrome Congress in Queensland, Australia being held October 2-5, 2024. Dr.

Invite to the Company’s R&D event on October 10, 2024 Medigene will host an R&D Event on Thursday, October 10, 2024, at 4.30 p.m. CEST / 10:30 a.m. ET. A live Q&A session will follow the formal ...